Advantages of nitroglycerin application in preoperative CTA for DIEP flap breast reconstruction [0.03%]
Ting Gao,Kun Li,Hao Lei et al.
Ting Gao et al.
A prospective single-arm pilot study evaluating [F-18]fluoroestradiol dedicated breast PET in invasive lobular carcinoma after neoadjuvant endocrine therapy [0.03%]
Kayla M Switalla,Natsuko Onishi,Ella F Jones et al.
Kayla M Switalla et al.
Association between trajectories of body fatness during childhood and puberty and post-pubertal breast composition in the growth and obesity Chilean cohort study [0.03%]
Ana Pereira,Pedro Ferrer,John Shepherd et al.
Ana Pereira et al.
Gary Zirpoli,Ruth M Pfeiffer,Julie R Palmer
Gary Zirpoli
Contributing factors of contralateral breast cancer in patients with BRCA mutation (ON-BRCA II study, KoREa-BSG 11) [0.03%]
Seon-Hi Shin,Sung Gwe Ahn,Jai Min Ryu et al.
Seon-Hi Shin et al.
Background: The cumulative risk of contralateral breast cancer (CBC) in BRCA1/2 carriers is remarkably higher than in non-carriers. This study aimed to investigate the clinicopathological predictors associated with the ri...
Transcriptomic deconvolution reveals prognostic immune signatures and immunotherapy-responsive subtypes in male breast cancer [0.03%]
Valentina Silvestri,Virginia Valentini,Agostino Bucalo et al.
Valentina Silvestri et al.
TTPAL inhibits the progression of breast cancer and reprograms tumor-associated macrophages by inhibiting JAK2/STAT3 signaling pathway [0.03%]
Lingfang Du,Lingyun Zhu,Yang Yang et al.
Lingfang Du et al.
Integrating tumor habitat heterogeneity with a hybrid deep learning architecture for ultrasound radiomics: a dual-center study on non-invasive prediction of PD-L1 expression in triple-negative breast cancer [0.03%]
Zhiyong Li,Huanzhong Su,Han Xiao et al.
Zhiyong Li et al.
CLIC3 is upregulated across all subtypes of breast cancer and plays a key role in cell migration, invasion and growth in soft agar [0.03%]
Paul Mellor,Shari E Smith,Stephanie Kendall et al.
Paul Mellor et al.
Risk factors for ductal carcinoma in situ: comparisons with invasive breast cancer [0.03%]
导管原位癌的影响因素及其与乳腺浸润性癌的比较研究
Janine V Abe,Jami Fukui,Lynne R Wilkens et al.
Janine V Abe et al.
Background: Ductal carcinoma in situ (DCIS) is a precursor of invasive breast cancer; however, the majority of DCIS tumors do not progress to invasive breast cancer. Elucidating shared and distinct risk factors for DCIS a...